Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Investing.com - Citizens has reiterated a Market Outperform rating and $8.50 price target on AG Mortgage Investment Trust (NYSE:MITT), which currently trades at $7.20 and offers an impressive 11.67% dividend yield. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value assessment.
The firm noted that AG Mortgage’s second-quarter earnings were negatively affected by legacy WMC commercial loans moving into non-accrual status, with capital reallocation expected in late 2025 or early 2026, which should improve forward earnings.
Following the second quarter, AG Mortgage refinanced expensive structured repo inherited from WMC into lower current market rates, freeing up $39 million in capital.
Citizens expects the improved earnings trend from Arc Home to continue, citing a more efficient expense base, new product offerings, and momentum from the 45 basis point drop in mortgage rates in the third quarter.
The firm anticipates strong tailwinds for improved earnings over the next few quarters, potentially leading to a higher dividend and improved valuation for AG Mortgage shares.
In other recent news, AG Mortgage Investment Trust Inc . reported its financial results for the second quarter of 2025, revealing an earnings per share (EPS) of $0.18. This figure fell short of analysts’ expectations, which had projected an EPS of $0.24, indicating a 25% miss. Additionally, the company’s revenue forecast of $21.52 million was not met. These developments are part of the latest updates concerning the company. While the earnings and revenue results were below forecasts, no information on mergers or acquisitions was provided. Analyst opinions or changes in stock ratings were also not mentioned in the recent updates. These recent developments provide investors with important insights into AG Mortgage Investment Trust Inc.’s financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.